https://www.neurotype.io 2026-04-24T21:24:54.147Z weekly 1 https://www.neurotype.io/answers 2026-04-24T21:24:54.147Z weekly 0.8 https://www.neurotype.io/definitions 2026-04-24T21:24:54.147Z weekly 0.8 https://www.neurotype.io/answers/eeg-biomarkers-relapse-risk-sud 2026-04-24T21:24:54.147Z weekly 0.7 https://www.neurotype.io/answers/cue-reactivity-biomarkers-cds-oud 2026-04-24T21:24:54.147Z weekly 0.7 https://www.neurotype.io/answers/neurofeedback-reduce-cue-induced-craving 2026-04-24T21:24:54.147Z weekly 0.7 https://www.neurotype.io/answers/self-reported-vs-biomarker-craving-assessment 2026-04-24T21:24:54.147Z weekly 0.7 https://www.neurotype.io/answers/how-cue-induced-craving-appears-eeg-erp 2026-04-24T21:24:54.147Z weekly 0.7 https://www.neurotype.io/answers/evidence-cue-induced-craving-predicts-relapse 2026-04-24T21:24:54.147Z weekly 0.7 https://www.neurotype.io/answers/interpreting-craving-biomarker-changes-across-treatment 2026-04-24T21:24:54.147Z weekly 0.7 https://www.neurotype.io/answers/patient-appropriateness-eeg-craving-assessment 2026-04-24T21:24:54.147Z weekly 0.7 https://www.neurotype.io/definitions/neurotype 2026-04-24T21:24:54.147Z weekly 0.7 https://www.neurotype.io/definitions/neuromarkr 2026-04-24T21:24:54.147Z weekly 0.7 https://www.neurotype.io/definitions/modit 2026-04-24T21:24:54.147Z weekly 0.7